Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)Д. В. Буханова, С. И. Глухова, Б. С. Белов et al.|Meditsinskiy sovet = Medical Council|2019Cited by 14
THU0127 IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM 5-YEAR FOLLOW UPД. В. Буханова, M. Cherkasova, Б. С. Белов et al.|Annals of the Rheumatic Diseases|2019Cited by 9
Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseasesД. В. Буханова, М. Е. Диатроптов, G. Lukina et al.|Meditsinskiy sovet = Medical Council|2018Cited by 9
INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSГ. М. Тарасова, Т. В. Попкова, Б. С. Белов et al.|Rheumatology Science and Practice|2018Cited by 7
FRI0212 USE OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP OF IMMUNOGENICITY WITH THERAPYGalina Tarasova, Т. В. Попкова, Б. С. Белов et al.|Annals of the Rheumatic Diseases|2019Cited by 7